|
|
||||||||
Department of Internal Medicine II, Chiba University School of Medicine, Chiba, Japan
Memory T cells respond in several functionally different ways from
naive T cells and thus function as efficient effector cells. In this
study we showed that primed T cells were more resistant to Fas-mediated
activation-induced cell death (AICD) than naive T cells using
OVA-specific TCR transgenic DO10 mice and Fas-deficient DO10
lpr/lpr mice. We found that apoptosis was efficiently
induced in activated naive T cells at 48 and 72 h after Ag
restimulation (OVA peptide; 0.3 and 3 µM), whereas apoptosis was not
significantly increased in activated primed T cells at 2472 h after
Ag restimulation. We further showed that the resistance to AICD in
primed T cells was due to the decreased sensitivity to apoptosis
induced by Fas-mediated signals, but TCR-mediated signaling equally
activated both naive and primed T cells to induce Fas and Fas ligand
expressions. Furthermore, we demonstrated that primed T cells expressed
higher levels of Fas-associated death domain-like IL-1
-converting
enzyme inhibitory protein (FLIP), an inhibitor of Fas-mediated
apoptosis, at 2448 h after Ag restimulation than naive T cells. In
addition, Bcl-2 expression was equally observed between activated naive
and primed T cells after Ag restimulation. Thus, these results indicate
that naive T cells are sensitive to Fas-mediated AICD and are easily
deleted by Ag restimulation, while primed/memory T cells express higher
levels of FLIP after Ag restimulation, are resistant to Fas-mediated
AICD, and thus function as efficient effector cells for a longer
period.
This article has been cited by other articles:
![]() |
J. Yang, M. O. Brook, M. Carvalho-Gaspar, J. Zhang, H. E. Ramon, M. H. Sayegh, K. J. Wood, L. A. Turka, and N. D. Jones Allograft rejection mediated by memory T cells is resistant to regulation PNAS, December 11, 2007; 104(50): 19954 - 19959. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. K. McKinstry, S. Golech, W.-H. Lee, G. Huston, N.-P. Weng, and S. L. Swain Rapid default transition of CD4 T cell effectors to functional memory cells J. Exp. Med., September 3, 2007; 204(9): 2199 - 2211. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Arce, H. F. Nawar, M. W. Russell, and T. D. Connell Differential Binding of Escherichia coli Enterotoxins LT-IIa and LT-IIb and of Cholera Toxin Elicits Differences in Apoptosis, Proliferation, and Activation of Lymphoid Cells Infect. Immun., May 1, 2005; 73(5): 2718 - 2727. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Dondi, G. Roue, V. J. Yuste, S. A. Susin, and S. Pellegrini A Dual Role of IFN-{alpha} in the Balance between Proliferation and Death of Human CD4+ T Lymphocytes during Primary Response J. Immunol., September 15, 2004; 173(6): 3740 - 3747. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. S. Zand, B. J. Briggs, A. Bose, and T. Vo Discrete Event Modeling of CD4+ Memory T Cell Generation J. Immunol., September 15, 2004; 173(6): 3763 - 3772. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Yang, K. Sato, T. Aprahamian, N. J. Brown, J. Hutcheson, A. Bialik, H. Perlman, and K. Walsh Endothelial Overexpression of Fas Ligand Decreases Atherosclerosis in Apolipoprotein E-Deficient Mice Arterioscler. Thromb. Vasc. Biol., August 1, 2004; 24(8): 1466 - 1473. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Carbonneil, H. Saidi, V. Donkova-Petrini, and L. Weiss Dendritic cells generated in the presence of interferon-{alpha} stimulate allogeneic CD4+ T-cell proliferation: modulation by autocrine IL-10, enhanced T-cell apoptosis and T regulatory type 1 cells Int. Immunol., July 1, 2004; 16(7): 1037 - 1052. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Gati, N. Guerra, C. Gaudin, S. Da Rocha, B. Escudier, Y. Lecluse, A. Bettaieb, S. Chouaib, and A. Caignard CD158 Receptor Controls Cytotoxic T-Lymphocyte Susceptibility to Tumor-Mediated Activation-Induced Cell Death by Interfering with Fas Signaling Cancer Res., November 1, 2003; 63(21): 7475 - 7482. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Molto, P. Rayman, E. Paszkiewicz-Kozik, M. Thornton, L. Reese, J. C. Thomas, T. Das, D. Kudo, R. Bukowski, J. Finke, et al. The Bcl-2 Transgene Protects T Cells from Renal Cell Carcinoma-mediated Apoptosis Clin. Cancer Res., September 15, 2003; 9(11): 4060 - 4068. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Jaleco, L. Swainson, V. Dardalhon, M. Burjanadze, S. Kinet, and N. Taylor Homeostasis of Naive and Memory CD4+ T Cells: IL-2 and IL-7 Differentially Regulate the Balance Between Proliferation and Fas-Mediated Apoptosis J. Immunol., July 1, 2003; 171(1): 61 - 68. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Askenasy, E. S. Yolcu, Z. Wang, and H. Shirwan Display of Fas Ligand Protein on Cardiac Vasculature as a Novel Means of Regulating Allograft Rejection Circulation, March 25, 2003; 107(11): 1525 - 1531. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. C. Fanzo, C.-M. Hu, S. Y. Jang, and A. B. Pernis Regulation of Lymphocyte Apoptosis by Interferon Regulatory Factor 4 (IRF-4) J. Exp. Med., February 3, 2003; 197(3): 303 - 314. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Chastagner, J. Reddy, and J. Theze Lymphoadenopathy in IL-2-Deficient Mice: Further Characterization and Overexpression of the Antiapoptotic Molecule Cellular FLIP J. Immunol., October 1, 2002; 169(7): 3644 - 3651. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Pantenburg, F. Heinzel, L. Das, P. S. Heeger, and A. Valujskikh T Cells Primed by Leishmania major Infection Cross-React with Alloantigens and Alter the Course of Allograft Rejection J. Immunol., October 1, 2002; 169(7): 3686 - 3693. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Grayson, L. E. Harrington, J. G. Lanier, E. J. Wherry, and R. Ahmed Differential Sensitivity of Naive and Memory CD8+ T Cells to Apoptosis in Vivo J. Immunol., October 1, 2002; 169(7): 3760 - 3770. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Srinivasan, I. E. Gienapp, S. S. Stuckman, C. J. Rogers, S. D. Jewell, P. T. P. Kaumaya, and C. C. Whitacre Suppression of Experimental Autoimmune Encephalomyelitis Using Peptide Mimics of CD28 J. Immunol., August 15, 2002; 169(4): 2180 - 2188. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Zhu, L. Luo, Y. Chen, D. W. Paty, and M. S. Cynader Intrathecal Fas Ligand Infusion Strengthens Immunoprivilege of Central Nervous System and Suppresses Experimental Autoimmune Encephalomyelitis J. Immunol., August 1, 2002; 169(3): 1561 - 1569. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Banz, C. Pontoux, and M. Papiernik Modulation of Fas-Dependent Apoptosis: A Dynamic Process Controlling Both the Persistence and Death of CD4 Regulatory T Cells and Effector T Cells J. Immunol., July 15, 2002; 169(2): 750 - 757. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Krueger, S. Baumann, P. H. Krammer, and S. Kirchhoff FLICE-Inhibitory Proteins: Regulators of Death Receptor-Mediated Apoptosis Mol. Cell. Biol., December 15, 2001; 21(24): 8247 - 8254. [Full Text] [PDF] |
||||
![]() |
P. Gorak-Stolinska, J.-P. Truman, D. M. Kemeny, and A. Noble Activation-induced cell death of human T-cell subsets is mediated by Fas and granzyme B but is independent of TNF-{alpha} J. Leukoc. Biol., November 1, 2001; 70(5): 756 - 766. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Srinivasan, R. M. Wardrop, I. E. Gienapp, S. S. Stuckman, C. C. Whitacre, and P. T. P. Kaumaya A Retro-Inverso Peptide Mimic of CD28 Encompassing the MYPPPY Motif Adopts a Polyproline Type II Helix and Inhibits Encephalitogenic T Cells In Vitro J. Immunol., July 1, 2001; 167(1): 578 - 585. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Poulaki, N. Mitsiades, M. E. Romero, and M. Tsokos Fas-mediated Apoptosis in Neuroblastoma Requires Mitochondrial Activation and Is Inhibited by FLICE Inhibitor Protein and bcl-2 Cancer Res., June 1, 2001; 61(12): 4864 - 4872. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Zhang, T. Bardos, K. Mikecz, A. Finnegan, and T. T. Glant Impaired Fas Signaling Pathway Is Involved in Defective T Cell Apoptosis in Autoimmune Murine Arthritis J. Immunol., April 15, 2001; 166(8): 4981 - 4986. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Yoshikawa, Y. Nakajima, and K. Tasaka Enhanced Expression of Fas-Associated Death Domain-Like IL-1-Converting Enzyme (FLICE)-Inhibitory Protein Induces Resistance to Fas-Mediated Apoptosis in Activated Mast Cells J. Immunol., December 1, 2000; 165(11): 6262 - 6269. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Kirchhoff, W. W. Muller, A. Krueger, I. Schmitz, and P. H. Krammer TCR-Mediated Up-Regulation of c-FLIPshort Correlates with Resistance Toward CD95-Mediated Apoptosis by Blocking Death-Inducing Signaling Complex Activity J. Immunol., December 1, 2000; 165(11): 6293 - 6300. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Suzuki and P. J. Fink The dual functions of Fas ligand in the regulation of peripheral CD8+ and CD4+ T cells PNAS, February 15, 2000; 97(4): 1707 - 1712. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-W. He and M. J. Bevan High Level Expression of CD43 Inhibits T Cell Receptor/CD3-mediated Apoptosis J. Exp. Med., December 20, 1999; 190(12): 1903 - 1908. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |